过去一年中添加的文章，按日期排序
[HTML][HTML] Review 1:" The Safety of Antivirals and Neutralising Monoclonal Antibodies Used in Prehospital Treatment of Covid-19"
P Htoo - Rapid Reviews Infectious Diseases, 2024 - rrid.mitpress.mit.edu
10 天前 - … an important safety question on the antiviral medications used for COVID-19. Overall,
the … Overall, the authors compared COVID-19 patients treated with antiviral medications to …
the … Overall, the authors compared COVID-19 patients treated with antiviral medications to …
Azvudine versus Paxlovid in COVID‐19: A systematic review and meta‐analysis
16 天前 - … and safety of azvudine versus nirmatrelvir/ritonavir (Paxlovid) in treating coronavirus
disease 2019 (COVID-19). … and safety of azvudine and Paxlovid in the treatment of COVID-…
disease 2019 (COVID-19). … and safety of azvudine and Paxlovid in the treatment of COVID-…
A review on recent theoretical approaches made in the discovery of potential Covid-19 therapeutics
AK Bhattacharjee - Journal of Mathematical Chemistry, 2024 - Springer
25 天前 - … Probably, that is why only two drugs, PAXLOVID™ (… However despite initial success
of PAXLOVID and molnupiravir, … COVID-19 treatments, the drug should have a good safety …
of PAXLOVID and molnupiravir, … COVID-19 treatments, the drug should have a good safety …
Case report and literature review: management of Paxlovid (nirmatrelvir/ritonavir)-induced acute Tacrolimus toxicity in a systemic lupus erythematosus patient
C Jiang, X Yan, P Xia, X Luo, H Zheng, H Tong… - Frontiers in … - frontiersin.org
33 天前 - … -CoV-2, managing COVID-19 in patients with systemic lupus … demonstrates the
effectiveness and safety of utilizing CYP3A4 … COVID-19 cases in immunocompromised patients. …
effectiveness and safety of utilizing CYP3A4 … COVID-19 cases in immunocompromised patients. …
· A Retrospective Cohort Study of the Efficacy and Safety of Oral Azvudine Versus Paxlovid in Elderly Hospitalized COVID-19 Patients Aged Over 60 Years
B Yu, H Wang, G Li, J Sun, H Luo, M Yang, M Cheng… - papers.ssrn.com
36 天前 - … Safety analysis We assessed and compared the safety of Azvudine and Paxlovid
in elderly patients with COVID-19 through collecting adverse event in both groups (Table 3). …
in elderly patients with COVID-19 through collecting adverse event in both groups (Table 3). …
Telemedicine for prescribing nirmatrelvir/ritonavir: Safety, logistics, and challenges
T Liebenstein, M Mailig, CJ Crnich… - Open Forum …, 2024 - academic.oup.com
39 天前 - … Nirmatrelvir/ritonavir can be a useful COVID-19 treatment but is … of concomitant
medications is a key safety element. … Paxlovid [emergency use authorization fact sheet]. New …
medications is a key safety element. … Paxlovid [emergency use authorization fact sheet]. New …
[HTML][HTML] Synthesis and in silico inhibitory action studies of azo-anchored imidazo[4,5-b]indole scaffolds against the COVID-19 main protease (Mpro)
D Geedkar, A Kumar, P Sharma - Scientific Reports, 2024 - nature.com
47 天前 - … a range of concentrations, affirming its favorable safety profile and potential suitability.
The … When compared with the other standard drug Paxlovid, ten azo-anchored derivatives …
The … When compared with the other standard drug Paxlovid, ten azo-anchored derivatives …
Short-term pregnancy outcomes and drug interactions after simultaneous exposure to Nematavir/Ritonavir (Paxlovid) and immunosuppressants in pregnant women
X Zhu, Q Huang, L Mo, F Fu, S Zhou, Y Feng, C Yang - 2024 - researchsquare.com
51 天前 - … regarding the safety of Paxlovid for the treatment of novel coronavirus infection during
pregnancy… Moreover, it should be noted that the ritonavir component of paxlovid acts as a …
pregnancy… Moreover, it should be noted that the ritonavir component of paxlovid acts as a …
Viral Kinetics Model of SARS‐CoV‐2 Infection Informs Drug Discovery, Clinical Dose, and Regimen Selection
AM Claas, M Lee, PH Huang… - Clinical …, 2024 - Wiley Online Library
58 天前 - … an important tool to project safety and efficacy of novel or … replicative
nirmatrelvir/ritonavir (Paxlovid®) and neutralizing … for different classes of COVID-19 treatments. …
nirmatrelvir/ritonavir (Paxlovid®) and neutralizing … for different classes of COVID-19 treatments. …
Concomitant and sequential administration of nirmatrelvir‐ritonavir and azvudine in patients with COVID‐19 caused by the Omicron variant: Safety and efficacy
GB Chen, YR Zheng, YN Yu, LM Liang, C Chen… - …, 2024 - Wiley Online Library
62 天前 - … the safety and efficacy of nirmatrelvirritonavir (Paxlovid®) and azvudine when
administered sequentially or concomitantly in patients with coronavirus 2019 (COVID‐19) caused …
administered sequentially or concomitantly in patients with coronavirus 2019 (COVID‐19) caused …